血紅蛋白病市場:按測試類型、按適應症、按最終用戶、按地區-規模、份額、展望、機會分析，2023-2030年

血紅蛋白異常病是一組遺傳性疾病，其中血紅蛋白分子的產生和結構存在異常。 血紅蛋白病是一個醫學術語，指一組主要影響紅細胞的遺傳性血液疾病和疾病。 鐮狀細胞病 (SCD) 是一種血液疾病，當異常血紅蛋白損害紅細胞並使紅細胞變形時就會發生這種疾病。 它大致分為由血紅蛋白基因突變引起的結構性血紅蛋白病和由正常血紅蛋白分子變化引起的地中海貧血。 主要的結構血紅蛋白變體是 HbS、HbE 和 HbC。 地中海貧血的主要類型是ALPHA-地中海貧血和BETA-地中海貧血。 一些導致血紅蛋白異常的疾病也會影響血紅蛋白的產生，因此這兩種疾病可能會重疊。

一些血紅蛋白異常不會引起病理或貧血，因此通常不被歸類為血紅蛋白病。 常見症狀包括劇烈疼痛、呼吸短促、脾臟腫大以及兒童發育遲緩。 血紅蛋白病是一組由紅細胞中血紅蛋白異常引起的疾病。

市場動態

為了擴大產品組合，市場主要參與者越來越多地採用合作夥伴關係等有機增長戰略，預計這將在預測期內推動市場增長。 例如，2022 年 6 月，美國臨床階段基因編輯上市公司 Precision BioSciences 與製藥公司諾華公司 (Novartis AG) 宣佈建立合作夥伴關係，開發針對血液疾病的新型基因療法。

本研究的主要特點

• 本報告對全球血紅蛋白病市場進行了深入分析，提供了以 2022 年為基準年的預測期內（2023-2030 年）的市場規模和復合年增長率 (CAGR%)。
• 它揭示了各個細分市場的潛在收入機會，並概述了該市場有吸引力的投資主張矩陣。
• 它還提供了有關市場驅動因素、限制因素、機遇、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
• 根據以下參數對全球血紅蛋白病市場主要參與者進行概況分析，包括公司亮點、產品組合、主要亮點、財務業績和戰略。
• 本研究涵蓋的主要公司包括 Anamol Laboratories Pvt. Ltd., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Zentech, Sebia, Sysmex Europe SE, Nanjing Poclight Biotechnology Co., Ltd, Abbott, Danaher, ReachBio LLC, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nexcelom Bioscience LLC., NIHON KOHDEN CORPORATION, Siemens Healthcare GmbH, CRISPR Therapeutics.。
• 該報告的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 全球血紅蛋白病市場報告面向該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和財務分析師。
• 利益相關者可以通過用於分析全球血紅蛋白病市場的各種策略矩陣來促進決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫

第 2 章市場展望

• 報告摘要
  • 市場定義和範圍
• 執行摘要
• 連貫的機會地圖 (COM)

第 3 章市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 制約因素
  • 市場機會
• 影響分析
• 主要亮點
• 產品發布
• 技術進步
• PEST分析
• 監管場景
• 併購

第 4 章全球血紅蛋白病市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 經濟影響
• 關於 COVID-19 的流行病學
• 對供需的影響

第 5 章全球血紅蛋白病市場，按測試類型，2017-2030 年

• 常規紅細胞 (RBC) 計數
• 基因檢測
• 高效液相色譜法檢測血紅蛋白
• 血紅蛋白等電聚焦 (Hb IEF)
• 血紅蛋白電泳 (Hb ELP)
• 血紅蛋白溶解度測試

第 6 章全球血紅蛋白病市場（按適應症），2017-2030 年

• 鐮狀細胞病
• Beta地中海貧血
• 阿爾法地中海貧血

第 7 章全球血紅蛋白病市場，按最終用戶劃分，2017-2030 年

• 醫院
• 診斷實驗室
• 醫務室

第 8 章全球血紅蛋白病市場:地區，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 歐洲其他地區
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 亞太地區其他地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第 9 章競爭格局

• Anamol Laboratories Pvt. Ltd.
• Bio-Rad Laboratories, Inc.
• PerkinElmer Inc.
• Zentech
• Sebia
• Sysmex Europe SE
• Nanjing Poclight Biotechnology Co., Ltd
• Abbott
• Danaher
• ReachBio LLC
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Nexcelom Bioscience LLC.
• NIHON KOHDEN CORPORATION
• Siemens Healthcare GmbH
• CRISPR Therapeutics

第 10 章

• 調查方法
• 關於出版商

Hemoglobinopathy are a group of disorders that are inherited, in which there is abnormal production or structure of the hemoglobin molecule. Hemoglobinopathy is the medical term for a group of inherited blood disorders and diseases that primarily affect red blood cells. Sickle cell disease (SCD) is one such blood disorder caused by the abnormal hemoglobin that damages and deforms red blood cells. There are two main groups, which are abnormal structural hemoglobin variants caused by mutations in the hemoglobin genes, and the thalassemias, which are caused by an alteration in normal hemoglobin molecules. The main structural hemoglobin variants are HbS, HbE and HbC. The main types of thalassemia are alpha-thalassemia and beta thalassemia. The two conditions may overlap because some conditions, which cause abnormalities in hemoglobin proteins also affect their production.

Some hemoglobin variants do not cause pathology or anemia, and thus are often not classed as hemoglobinopathies. Common symptoms of the condition include, severe pain, shortness of breath, enlarged spleen, and growth problems in children. It can be any group of disorders caused by the presence of variant hemoglobin in the red blood cells.

Market Dynamics

Increasing adoption of organic growth strategies, such as partnerships by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in June 2022, Precision BioSciences, a publicly traded American clinical stage gene editing company, and Novartis AG, a pharmaceutical corporation, announced that they have entered into a partnership to develop new gene therapy for blood disorders.

Key features of the study:

• This report provides in-depth analysis of the global hemoglobinopathy market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global hemoglobinopathy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study are Anamol Laboratories Pvt. Ltd., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Zentech, Sebia, Sysmex Europe SE, Nanjing Poclight Biotechnology Co., Ltd, Abbott, Danaher, ReachBio LLC, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nexcelom Bioscience LLC., NIHON KOHDEN CORPORATION, Siemens Healthcare GmbH, CRISPR Therapeutics.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global hemoglobinopathy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemoglobinopathy market

Detailed Segmentation:

• Global Hemoglobinopathy Market, By Test Type:
  • Routine Red Blood Cell (RBC) count
  • Genetic Testing
  • Hemoglobin by high performance liquid chromatography
  • Hemoglobin isoelectric focusing ( Hb IEF)
  • Hemoglobin electrophoresis (Hb ELP)
  • Hemoglobin solubility test
• Global Hemoglobinopathy Market, By Indication:
  • Sickle Cell Disease
  • Beta Thalassemia
  • Alpha Thalassemia
• Global Hemoglobinopathy Market, By End User:
  • Hospitals
  • Diagnostic Laboratories
  • Clinics
• Global Hemoglobinopathy Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Anamol Laboratories Pvt. Ltd.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Zentech
  • Sebia
  • Sysmex Europe SE
  • Nanjing Poclight Biotechnology Co., Ltd
  • Abbott
  • Danaher
  • ReachBio LLC
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Nexcelom Bioscience LLC.
  • NIHON KOHDEN CORPORATION
  • Siemens Healthcare GmbH.
  • CRISPR Therapeutics

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Test Type
  • Market Snapshot, By Indication
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Highlights
• Product Launch
• Technological Advancements
• PEST Analysis
• Regulatory Scenario
• Mergers and Acquisitions

4. Global Hemoglobinopathy Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Hemoglobinopathy Market, By Test Type, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Routine Red Blood Cell (RBC) count
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hemoglobin by high performance liquid chromatography
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hemoglobin isoelectric focusing ( Hb IEF)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hemoglobin electrophoresis (Hb ELP)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hemoglobin solubility test
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Hemoglobinopathy Market, By Indication, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Sickle Cell Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Beta Thalassemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Alpha Thalassemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Hemoglobinopathy Market, By End User, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Hemoglobinopathy Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Anamol Laboratories Pvt. Ltd.*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• PerkinElmer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zentech
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sebia
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sysmex Europe SE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nanjing Poclight Biotechnology Co., Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Danaher
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ReachBio LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nexcelom Bioscience LLC.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NIHON KOHDEN CORPORATION
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Siemens Healthcare GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• CRISPR Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us